Summary

Clinical impact of new approaches to oral anticoagulation therapy in atrial fibrillation

De Azúa Jiménez M, Gómez Bitrián J, Royo Hernández R, Aldea Molina E, Llera Guerra R, Miranda Harto P

Affiliation of the authors

Servicio de Urgencias. Medicina de Familia y Comunitaria. Hospital Clínico Universitario “Lozano Blesa”. Zaragoza, Spain.

DOI

Quote

De Azúa Jiménez M, Gómez Bitrián J, Royo Hernández R, Aldea Molina E, Llera Guerra R, Miranda Harto P. Clinical impact of new approaches to oral anticoagulation therapy in atrial fibrillation. Emergencias. 2009;21:405-9

Summary

Objective: To describe the oral anticoagulation therapy received by patients with atrial

fibrillation (AF) admitted in an Emergency Department Observation Unit (OU) and to

determine the adjusting degree of this therapy to the indications included in the

American Heart Association (AHA) protocols 2001 and 2006, and also the impact that it

has in the adjusting percentage of the indication change that has existed during this

period.

Method: Observational, prospective and no interventional trial. Patients admitted in an

OU diagnosed of AF for a 3 years consecutive period were included. General clinical data

were taken and from the most relevant AF and from the anticoagulant-antiplatelet

treatment prescribed when the patients were discharged from the OU. The adjusting

degree of this treatment was checked to both AHA protocols and the change percentage

in the indications that has implied the indication change of these guides.

Results: 789 patients were included (average age 67 years, 52% women): 90 (12%)

corresponding to chronic AF, 262 (33%) to first episodes and 436 (55%) to paroxystic AF.

From 185 patients with AF first episode discharged from de OU, 61 were prescribed with

anticoagulant therapy. From these, 52 were discharged with controlled AF (100% well

decoagulated, according to both guides) and 9 with sinusal rate (100% well decoagulated

according to the 2001 guides, but 55% according to the 2006 guides). From the 370

patients with paroxystic AF discharged, 167 (45%) were decoagulated, although according

to the 2001 guides should have been 54% (9% more than carried out in the OU) and

according to the 2006 guides 28% (17% less than carried out in the OU).

Conclusion: Anticoagulant prescription in AF in an Emergency Department doesn’t

adjust exactly to recommended in AHA guides, although the criteria changes produced

in those make possible a change from an undertreatment situation to another one of

overtreatment.

 

More articles by the authors

Leave a Reply

Your email address will not be published. Required fields are marked *